Both in Biotechnology
Protalix BioTherapeutics vs Invivyd
Over the past year PLX returned +7.1% and IVVD returned −63.9%; their daily moves had a correlation of 0.18.
PLX +7.1% IVVD −63.9%Growth of $1, one year, split-adjusted
| Metric | PLX | IVVD |
|---|---|---|
| Price | $2.56 | $0.5820 |
| Market cap | $206.3M | $171.5M |
| Today | −1.16% | +0.05% |
| 1 month | −5.5% | −29.2% |
| 6 months | +20.2% | −60.4% |
| Year to date | +42.2% | −76.4% |
| 1 year | +13.3% | −68.9% |
| Revenue growth (YoY) | +27.1% | +21.2% |
| Gross margin | 61.0% | 91.1% |
| Net margin | 19.0% | −310.8% |
| P/E (TTM) | 10.9× | — |
| Price / sales | 2.6× | 2.9× |
| Net cash | $40.7M | $160.1M |
| Dividend yield | — | — |
| Volatility (60d) | 44.7% | 107.8% |
| Short % of float | 4.7% | 15.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).